نتایج جستجو برای: tenofovir disproxil fumarate

تعداد نتایج: 10210  

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016
Rochelle P Walensky Tim H Horn A David Paltiel

Approximately 84% of human immunodeficiency virus (HIV)-infected US residents on antiretroviral therapy currently receive some form of tenofovir disoproxil fumarate (TDF) as part of their HIV treatment regimen. The TDF analogue tenofovir alafenamide (TAF) has demonstrated equal efficacy but with decreased renal injury and bone mineral density loss compared with TDF. We examine how much more soc...

Journal: :Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 2014

Journal: :Antimicrobial agents and chemotherapy 2011
Sihem Benaboud Alain Pruvost Patrick A Coffie Didier K Ekouévi Saïk Urien Elise Arrivé Stéphane Blanche Frédéric Théodoro Divine Avit François Dabis Jean-Marc Tréluyer Déborah Hirt

The aim was to evaluate emtricitabine (FTC) and tenofovir (TFV) neonatal ingestion through breast milk. Median TFV and FTC breast milk doses represented 0.03% and 2%, respectively, of the proposed oral infant doses. Neonatal simulated plasma concentrations were extremely low for TFV but between the half-maximal inhibitory concentration and the adult minimal expected concentration for FTC. The r...

Journal: :Antimicrobial agents and chemotherapy 2015
Kanokrat Rungtivasuwan Anchalee Avihingsanon Narukjaporn Thammajaruk Siwaporn Mitruk David M Burger Kiat Ruxrungtham Baralee Punyawudho Thitima Pengsuparp

Tenofovir (TFV) is eliminated by renal excretion, which is mediated through multidrug-resistant protein 2 (MRP2) and MRP4, encoded by ABCC2 and ABCC4, respectively. Genetic polymorphisms of these transporters may affect the plasma concentrations of tenofovir. Therefore, the aim of this study was to investigate the influence of genetic and nongenetic factors on tenofovir plasma concentrations. A...

Journal: :Clinical and experimental rheumatology 2009
D P Wanner A Tyndall U A Walker

We present an HIV-infected woman in whom antiretroviral treatment with tenofovir disoproxil fumarate (TDF) induced severe skeletal pain, synovial effusions and multiple fractures secondary to a Fanconi syndrome with hypophosphatemia and osteomalacia. TDF interferes with the replication of mitochondrial DNA in the proximal tubules of the kidney, which can explain the delayed onset of this form o...

Journal: :AIDS 2016
Amandine Gagneux-Brunon Elisabeth Botelho-Nevers Anne Frésard Frédéric Lucht

Tenofovir is the active metabolite of tenofovir disoproxil fumarate (TDF), a commonly used antiretroviral agent in HIV treatment and in HIV preexposure prophylaxis. After a long-term exposure, TDF is associated with kidney impairment. In the D:A:D study cohort of HIV-infected patients (22 603 HIV-infected patients with baseline estimated glomerular filtration rate (eGFR) 90 ml/min per 1.73 m), ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید